Ensoma
Drug DiscoveryWebsite
Operator of a biotech company intended to develop a genomic medicine in vivo approach to engineer any or all blood and immune cells to cure diseases. The company focuses on engineered vectors that per...
Valuation
$0
Share Price
N/A
Total Raised
$258M
Last Round
Later Stage VC (Series B1)
Sep 2025
Latest Funding Round
Later Stage VC (Series B1)
Sep 22, 2025
$53M
raised
Investors
+20 other investors